Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity-Reference-Cited by-同舟云学术

Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity

Published:2023-07 Issue: Volume:187 Page:58-64
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Chung Rainjade^ORCID,McKiernan James,Arpaia Nicholas,Marabelle Aurélien,Rouanne Mathieu^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. The urothelium: a multi-faceted barrier against a harsh environment;Jafari;Mucosal Immunol,2022

2. The dynamic roles of the bladder tumour microenvironment;Lee;Nat Rev Urol,2022

3. Goubet A.G., Rouanne M., Derosa L., et al. From mucosal infection to successful cancer immunotherapy. Nat Rev Urol. 2023 (in press).

4. Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille calmette-guérin;Mostafid;Eur Urol,2015

5. First-in-human intravesical delivery of pembrolizumab identifies immune activation in bladder cancer unresponsive to Bacillus Calmette-Guérin;Meghani;Eur Urol,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteria/Nanozyme Composites: New Therapeutics for Disease Treatment;Small Methods;2024-06-25

2. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

3. A Multi-Gene Signature of Non-Muscle-Invasive Bladder Cancer Identifies Patients Who Respond to Immunotherapies Including Bacillus Calmette–Guérin and Immune Checkpoint Inhibitors;International Journal of Molecular Sciences;2024-03-28

4. Identification of bladder cancer subtypes and predictive model for prognosis, immune features, and immunotherapy based on neutrophil extracellular trap-related genes;Scientific Reports;2023-11-27